146 related articles for article (PubMed ID: 24102090)
1. Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer.
Mozzoni P; Banda I; Goldoni M; Corradi M; Tiseo M; Acampa O; Balestra V; Ampollini L; Casalini A; Carbognani P; Mutti A
Biomarkers; 2013 Dec; 18(8):679-86. PubMed ID: 24102090
[TBL] [Abstract][Full Text] [Related]
2. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.
Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL
Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095
[TBL] [Abstract][Full Text] [Related]
3. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
5. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
7. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer.
Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A
Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859
[TBL] [Abstract][Full Text] [Related]
8. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.
Shen J; Todd NW; Zhang H; Yu L; Lingxiao X; Mei Y; Guarnera M; Liao J; Chou A; Lu CL; Jiang Z; Fang H; Katz RL; Jiang F
Lab Invest; 2011 Apr; 91(4):579-87. PubMed ID: 21116241
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of oxidative stress markers in exhaled breath condensate.
Chan HP; Tran V; Lewis C; Thomas PS
J Thorac Oncol; 2009 Feb; 4(2):172-8. PubMed ID: 19179892
[TBL] [Abstract][Full Text] [Related]
11. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?
Carpagnano GE; Lacedonia D; Palladino GP; Koutelou A; Martinelli D; Orlando S; Foschino-Barbaro MP
Eur J Clin Invest; 2012 May; 42(5):478-86. PubMed ID: 21955247
[TBL] [Abstract][Full Text] [Related]
12. Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
Patnaik SK; Kannisto ED; Mallick R; Vachani A; Yendamuri S
PLoS One; 2017; 12(7):e0181926. PubMed ID: 28742859
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic markers in breath condensate identify non-small cell lung cancer.
Gessner C; Rechner B; Hammerschmidt S; Kuhn H; Hoheisel G; Sack U; Ruschpler P; Wirtz H
Lung Cancer; 2010 May; 68(2):177-84. PubMed ID: 19647334
[TBL] [Abstract][Full Text] [Related]
14. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
15. Altered miR-143 and miR-150 expressions in peripheral blood mononuclear cells for diagnosis of non-small cell lung cancer.
Zeng XL; Zhang SY; Zheng JF; Yuan H; Wang Y
Chin Med J (Engl); 2013 Dec; 126(23):4510-6. PubMed ID: 24286416
[TBL] [Abstract][Full Text] [Related]
16. Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients.
Goldoni M; Caglieri A; Corradi M; Poli D; Rusca M; Carbognani P; Mutti A
Int Arch Occup Environ Health; 2008 Feb; 81(4):487-93. PubMed ID: 17724608
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer.
Yang Ai SS; Hsu K; Herbert C; Cheng Z; Hunt J; Lewis CR; Thomas PS
Respir Med; 2013 Jun; 107(6):911-8. PubMed ID: 23507584
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer.
Carpagnano GE; Foschino-Barbaro MP; Resta O; Gramiccioni E; Carpagnano F
Oncology; 2004; 66(3):180-4. PubMed ID: 15218307
[TBL] [Abstract][Full Text] [Related]
19. Serum miR-19a expression correlates with worse prognosis of patients with non-small cell lung cancer.
Lin Q; Chen T; Lin Q; Lin G; Lin J; Chen G; Guo L
J Surg Oncol; 2013 Jun; 107(7):767-71. PubMed ID: 23609137
[TBL] [Abstract][Full Text] [Related]
20. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]